The Hollings Cancer Center (HCC) Administration provides key services to facilitate and enhance scientific productivity and collaboration among its 122 faculty research members who are organized into four research programs and who utilize HCC-supported shared resources. Administrative services include: ? Coordination of and participation in Center-wide strategic planning and evaluation efforts. ? Stimulation and support of inter-, intra-programmatic, and multi-center interactions;services include targeted grant development support and consultation, meeting organization and documentation, and retreat/seminar/symposia coordination. ? Administrative oversight and support for HCC-supported shared resources including the establishment of user fees, billing, auditing, coordination of and participation in oversight committees, and evaluations. ? Coordination and oversight of all Center-related development/fundraising activities. ? Fiscal management and oversight of all HCC resources and university and MUSC Foundation accounts related to the Center. ? Facilities management of all assigned HCC space and equipment. ? Coordination of new faculty recruitment in collaboration with other university departments. ? Human resource management of Center staff. ? Management of HCC membership including new application processes and annual reviews. ? Administration of pilot projects and other internal research award processes. ? Computer networking and design of research management databases. ? Coordination of internal communications and public relations for all Center activities.

Public Health Relevance

The HCC Administration is an essential component of the overall Center's efforts in that it provides key services - fiscal management, meeting/project/program coordination, facilities management, and communications - to ensure that the Center is able to meet its mission, vision, and strategic goals.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA138313-06
Application #
8695840
Study Section
Subcommittee G - Education (NCI)
Project Start
2009-04-01
Project End
2019-03-31
Budget Start
2014-06-20
Budget End
2015-03-31
Support Year
6
Fiscal Year
2014
Total Cost
$129,070
Indirect Cost
$42,864
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29403
Wolfe, A M; Dunlap, K M; Smith, A C et al. (2018) Myxoma Virus M083 Is a Virulence Factor Which Mediates Systemic Dissemination. J Virol 92:
DeHart, David N; Fang, Diana; Heslop, Kareem et al. (2018) Opening of voltage dependent anion channels promotes reactive oxygen species generation, mitochondrial dysfunction and cell death in cancer cells. Biochem Pharmacol 148:155-162
Bai, Aiping; Bielawska, Alicja; Rahmaniyan, Mehrdad et al. (2018) Dose dependent actions of LCL521 on acid ceramidase and key sphingolipid metabolites. Bioorg Med Chem 26:6067-6075
Graboyes, Evan M; Kompelli, Anvesh R; Neskey, David M et al. (2018) Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg :
Burris, Jessica L; Rivera-Rivera, Jessica N; Armeson, Kent et al. (2018) Causal attributions and their impact on psychosocial functioning in head and neck cancer patient-caregiver dyads: a preliminary, longitudinal study. Qual Life Res :
Bea, Vivian J; Cunningham, Joan E; Alberg, Anthony J et al. (2018) Alcohol and Tobacco Use in an Ethnically Diverse Sample of Breast Cancer Patients, Including Sea Island African Americans: Implications for Survivorship. Front Oncol 8:392
Panneer Selvam, Shanmugam; Roth, Braden M; Nganga, Rose et al. (2018) Balance between senescence and apoptosis is regulated by telomere damage-induced association between p16 and caspase-3. J Biol Chem 293:9784-9800
Wrangle, John M; Velcheti, Vamsidhar; Patel, Manish R et al. (2018) ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Lancet Oncol 19:694-704
Janakiraman, Harinarayanan; House, Reniqua P; Gangaraju, Vamsi K et al. (2018) The Long (lncRNA) and Short (miRNA) of It: TGF?-Mediated Control of RNA-Binding Proteins and Noncoding RNAs. Mol Cancer Res 16:567-579
Jin, Junfei; Lu, Zhongyang; Li, Yanchun et al. (2018) LPS and palmitate synergistically stimulate sphingosine kinase 1 and increase sphingosine 1 phosphate in RAW264.7 macrophages. J Leukoc Biol 104:843-853

Showing the most recent 10 out of 536 publications